Skip to main content
Equibles

Avoro Capital Advisors LLC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1633313 NEW YORK, NY
Back to TSHA Full portfolio

Position in TSHA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$162,683,327
+$65,684,327 QoQ
Shares Held
23,888,888
+10.1% QoQ
Ownership
7.33%
of shares outstanding
% of Portfolio
1.46%
of 13F equity value
Holder Rank
#1
of 208 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Avoro Capital Advisors LLC holds $9,631,167,263 across 25 Biotechnology names. TSHA ranks #15 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ASND
Ascendis Pharma A/S
 5,111,111 $1,363,235,525
2 KRYS
Krystal Biotech, Inc.
 2,888,888 $1,073,713,002
3 MDGL
Madrigal Pharmaceuticals, Inc.
 1,833,333 $984,408,154
4 ARGX
Argenx SE
 1,000,000 $927,770,000
5 ARWR
Arrowhead Pharmaceuticals, Inc.
 11,355,555 $925,591,288
6 KYMR
Kymera Therapeutics, Inc.
 7,474,747 $857,129,238
7 RVMD
Revolution Medicines, Inc.
 2,297,000 $430,182,160
8 CYTK
Cytokinetics Inc
 4,999,999 $425,949,914

All Filings in TSHA

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $162,683,327 23,888,888
2026-03-31 $96,999,000 21,700,000
2025-12-31 $119,350,000 21,700,000
2025-09-30 $70,959,000 21,700,000
2025-06-30 $50,127,000 21,700,000
2025-03-31 $27,799,998 19,999,999
2024-12-31 $34,599,998 19,999,999
2024-09-30 $37,486,500 18,650,000
2024-06-30 $41,776,000 18,650,000
2024-03-31 $53,525,500 18,650,000
2023-12-31 $7,709,332 4,355,555
2023-09-30 $12,403,000 3,925,000